It’s got a good beat, and your cells can recycle to it. The “it” in this case is not a newly released hit song, but the under-appreciated B side of autophagy-related protein 8 (ATG8), a ubiquitin-like protein required for the formation of autophagosomal membranes. Until now, the A side has received almost all the attention. But by flipping the ATG8 protein 180°, scientists based at Washington University in St. Louis have discovered a whole new set of receptors that can draw cellular wallflowers—poorly folded proteins and dysfunctional organelles—into the autophagy dance.

The Washington University team, led by Richard S. Marshall, research scientist, and Richard Vierstra, professor of biology, published their findings in the journal Cell, in an article titled, “ATG8-Binding UIM Proteins Define a New Class of Autophagy Adaptors and Receptors.” The article could shed light on why autophagy sometimes fails, allowing defective cellular material to accumulate and contribute to disorders such as Huntington’s disease, Alzheimer’s, Parkinson’s disease, and Lou Gehrig’s Disease/ALS, where this trash blocks neurons from transmitting signals.

In autophagy, cells engulf unwanted material in vesicles that are then deposited in a trash bin called the vacuole or lysosome. There, the trash is degraded, and its building blocks are reused.

Key to this recycling process are the receptors that recognize the trash and tether it to ATG8, which lines the engulfing vesicle. Previously, all of these receptors were thought to be related and bound to ATG8 via the same mechanism.

“There is the binding site on ATG8 that everyone knew about before, and how it interacts with autophagy receptors,” Marshall said. “But we found that if you completely rotate the molecule 180°, there is the new site on the opposite side that recognizes a long list of additional cargo receptors. A whole slew of proteins in plants, yeast, and humans are using this new binding site and its suite of cognate receptors to interact with ATG8.

“Here we describe a new class of ATG8 interactors that exploit ubiquitin-interacting motif (UIM)-like sequences for high-affinity binding to an alternative ATG8 interaction site,” wrote the authors of the new study. “Assays with candidate UIM-containing proteins together with unbiased screens identified a large collection of UIM-based ATG8 interactors in plants, yeast, and humans.”

The ubiquitin-interacting motif, or UIM, had not previously been linked to autophagy.

“This is a completely different mechanism of interaction,” Marshall stressed. “Its discovery represents an explosion in the number of potential ATG8-interacting proteins that could be controlling autophagy, all of which are using this new site.” Understanding how these new cargo receptors work could shed light on new preventive or therapeutic targets relevant to human disease.

Marshall and Vierstra also described a particular receptor in this new collection that helps trash a key protein called CDC48 or p97.

New factors have been identified that regulate autophagic vesicle dynamics. [Cell]

“Analysis of a subset also harboring ubiquitin regulatory X (UBX) domains revealed a role for UIM-directed autophagy in clearing nonfunctional CDC48/p97 complexes, including some impaired in human disease,” the article detailed.

Proteotoxic stress occurs when faulty proteins build up, and cells can’t get rid of them. CDC48 is part of this process, but even it can go bad. The faulty proteins and CDC48 tend to start forming tangled aggregates like those recognized in Alzheimer’s and Parkinson’s disease.

“CDC48 is an unfoldase, which means it grabs proteins, unfolds them, and delivers them to proteases that will degrade them,” Vierstra explained. “Keeping your protein complement happy and functional requires CDC48. If it doesn’t work, you have all kinds of problems, including clogged neurons.”

Vierstra noted that CDC48 exists as a hexamer—a molecular complex with six repeating units—and even one bad copy within the complex will send the whole thing to autophagic turnover.

“As they say, one bad apple seems to spoil the whole barrel,” Vierstra pointed out. “But in several neurological disorders, you only need one faulty CDC48 to go awry to have bad consequences—if you can’t clean up its mess.”

Previous articleKeytruda Benefits Reported at AACR for Advanced Small Cell Lung Cancer
Next articlePeanut Allergen Inhibitor Developed Using Nanoparticles